The primary objective of this study is to evaluate the impact of Cardiac Contractility Modulation (CCM) therapy on the initiation and up-titration of Guideline-Directed Medical Therapy (GDMT) in patients with heart failure (HF). This will be assessed by the change in Quad Medication Score (QMS) from baseline (pre-CCM) to 6-month following post-CCM device implant.
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-08-28; most recent amendment 2025-07-08.
Status change: Not Yet Recruiting → Recruiting2025-04-02